Plant Biology/Schedule I drugs/New Scientific Consortiums Needed

by | Mar 4, 2018 | cannabis, health and well being, neurobiology, plant biology

Using Nature’s Intelligence to Take Advantage of Evolved Nash Equilibrium Principles to Unlock Value and Support Entrepreneurs Overlooked by Most of the Investment Community

________________________________

Our “Phoenix Investing” service area involves investing research on the following: 1) multi-capitalization public equities and 2) digital assets for experiential learning of how to apply our living systems investing principles (we do not chase the herd, instead seeking pockets of real value creation). 

Investors can expect a mixture of written content as well as podcasts, live webinars, and videos with interdisciplinary experts. We are not investment advisors to invest at your own risk. This is for educational purposes only.  

Both our areas of focus tend to be volatile and risky with big sell offs following large bubbles and then rising again. Both areas can benefit from our natural intelligence perspective, which is unique for finding opportunities away from the herd and managing layers of risks not possible using other approaches.

We focus on the edge of chaos in misunderstood, overlooked, off the radar, and turnaround situations. It is a fun service area. Keep in mind that this is not a typical investment research product. We discuss coherence and alignment as it relates to our living systems investing principles with the intention of helping to unblock value in these important companies and projects. Phoenix Investing is tightly integrated with The Pythia Scrolls.

We also give members a chance to present their own ideas, as long as they use our natural intelligence systems principles.

We discuss global companies that are both coherent and incoherent with the principles. The degree of coherence is especially helpful in determining which companies have the best systemic value propositions and which ones are exposed to the most risk during these liminal times. We also use the principles to brainstorm about how to help companies with exciting products and services that may be struggling and do not fit very well in the current winner take all system.

You can make venture capital-like returns with our strategies over shorter time frames. However, there is also much more volatility and risk, so our focus and approach is not for the risk averse. Some areas where we focus can be highly predatory and the companies illiquid, but we also focus on newly emerging industries and exciting new trends. We use game theory principles in their higher potential with the intention to support these important edge entrepreneurs. We seek high integrity investors, as this space attracts many sleazy people who do not care about systemic value creation.

“Phoenix Investing” is highly synergistic with and integrated into our foundational service area “The Pythia Scrolls” (interdisciplinary, networked intelligence and living systems investing trends research) and is the only way to access “Phoenix Investing” content.

Contact us here or contact Lynn Marie DePippo directly here: lynndepippo@gmail.com if you are interested to explore our new founding membership in The Pythia Scrolls which contains the following service areas: 1) Codex – educational materials; 2) The Scrolls – interactive trends research 3) Phoenix Investing.

 

The subject of medical use of cannabis is a very topical subject these days and is increasingly legal in many states but still not at the Federal level in the US.  It is considered a schedule 1 drug that implies it has no medical utility (hmmmm… really… are we serious).  It is a bit ridiculous that we have all this investment and businesses in Canada and the US and hardly any of it is going toward scientific research.  Currently, it is very difficult for scientists to study schedule 1 drugs.  This particular article discusses the significant difficulty that one neuroscientist, Yasmin Hurd, is having studying an ingredient in marijuana for drug overdoses due to this schedule 1 regulation.  She is working on putting together a global consortium of scientists to work on this.  From a regulatory perspective, a consortium like this could work for other medical studies as well and give the regulators around the world a sensible option to onerous regulation to this widespread problem.  

If we are serious about finding cost effective and safe medicines as well as dealing with epidemics like opioid addictions, then we need to take these scientific consortiums seriously and deal with these onerous and outdated regulatory barriers.  Marijuana, like other plants has a complex mixture of chemicals that often have synergies when they are mixed together.  THC may be problematic on its own but work better when mixed with other compounds.  We can leverage billions of years of evolution to do the hard work for us, but not with regulation that makes no sense anymore and blocks the research of scientists around the world.

Recently, there are more discussions at the FDA level to raise more regulatory barriers for other plant compounds that may act like opioids.  We need to listen to our scientists and come up with a more sensible approach to dealing with these serious issues than regulatory approaches that block progress and solutions to problems.  Fortunately, scientists have many new scientific and technical tools that can accelerate this area of research and work to find solutions that seemed impossible only ten years ago.

Here is a link to the article:

This scientist is testing a marijuana ingredient as a way to prevent relapse. It’s a daunting task